Qingling Wu

机构：Minzu University of China, Wenzhou Polytechnic, Regend Therapeutics (China)

发表论文 41 篇 · 总被引 1094 次 · h-index 15

代表论文

• Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer (2020 · Cellular and Molecular Immunology · 被引 260)
• Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells (2023 · Journal of Hematology & Oncology · 被引 47)
• Chemical composition and pharmacological properties of Flos sophorae immaturus, Flos sophorae and Fructus sophorae: a review (2023 · Journal of Future Foods · 被引 22)
• A long non‐coding RNA GATA6‐AS1 adjacent to GATA6 is required for cardiomyocyte differentiation from human pluripotent stem cells (2020 · The FASEB Journal · 被引 22)
• Complete genome sequence of Lactobacillus fermentum 9-4, a purine-degrading Lactobacillus probiotic isolated from Chinese fermented rice-flour noodles (2023 · Journal of Future Foods · 被引 12)
• Study of the Load Forecasting of a Wet Mill Based on the CEEMDAN-Refined Composite Multiscale Dispersion Entropy and LSTM Nerve Net (2022 · International Journal of Automation Technology · 被引 6)